Literature DB >> 19385736

An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.

Oriol Manuel1, Xiaoli L Pang, Atul Humar, Deepali Kumar, Karen Doucette, Jutta K Preiksaitis.   

Abstract

BACKGROUND: We studied human cytomegalovirus (CMV) donor-to-recipient transmission patterns in organ transplantation by analyzing genomic variants on the basis of CMV glycoprotein B (gB) genotyping.
METHODS: Organ transplant recipients were included in the study if they had CMV viremia, if they had received an organ from a CMV-seropositive donor, and if there was at least 1 other recipient of an organ from the same donor who developed CMV viremia. Genotypes (gB1-4) were determined by real-time polymerase chain reaction.
RESULTS: Forty-seven recipients of organs from 21 donors developed CMV viremia. Twenty-three recipients had a pretransplant donor/recipient (D/R) CMV serostatus of D(+)/R(+), and 24 had a serostatus of D(+)/R(-). The prevalences of genotypes in recipients were as follows: for gB1, 51% (n = 24); for gB2, 19% (n = 9); for gB3, 9% (n = 4); for gB4, 0% (n = 0); and for mixed infection, 21% (n = 10). Recipients of an organ from a common donor had infection with CMV of the same gB genotype in 12 (57%) of 21 instances. Concordance between genotypes was higher among seronegative (i.e., D(+)/R(-)) recipients than among seropositive (D(+)/R(+)) recipients, although discordances resulting from the transmission of multiple strains were seen. In seropositive recipients, transmission of multiple strains from the donor could not be differentiated from reactivation of a recipient's own strains.
CONCLUSION: Our analysis of strain concordance among recipients of organs from common donors showed that transmission of CMV has complex dynamic patterns. In seropositive recipients, transmission or reactivation of multiple CMV strains is possible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19385736     DOI: 10.1086/598952

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.

Authors:  Jutte J C de Vries; Els Wessels; Anna M H Korver; Annemiek A van der Eijk; Lisette G Rusman; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.

Authors:  Javier Carbone; Nallibe Lanio; Antonio Gallego; Florian Kern; Joaquin Navarro; Patricia Muñoz; Roberto Alonso; Pilar Catalán; Juan Fernández-Yáñez; Jesús Palomo; Manuel Ruiz; Eduardo Fernández-Cruz; Elizabeth Sarmiento
Journal:  J Clin Immunol       Date:  2012-02-29       Impact factor: 8.317

3.  Cytomegalovirus in hematopoietic stem cell transplant recipients.

Authors:  Per Ljungman; Morgan Hakki; Michael Boeckh
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

4.  Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.

Authors:  Ghady Haidar; Michael Boeckh; Nina Singh
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 5.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

6.  Geographic Distribution of Cytomegalovirus Serology in Kidney and Pancreas Transplant Recipients in the United States.

Authors:  Margaret R Jorgenson; Sandesh Parajuli; Nicholas Marka; Glen E Leverson; Jeannina A Smith; Didier A Mandelbrot; Jon S Odorico
Journal:  Transplant Direct       Date:  2021-05-25

Review 7.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

8.  Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.

Authors:  Andrea R McWhorter; Lee M Smith; Laura L Masters; Baca Chan; Geoffrey R Shellam; Alec J Redwood
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

Review 9.  Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus.

Authors:  Dante P Melendez; Raymund R Razonable
Journal:  Infect Drug Resist       Date:  2015-08-05       Impact factor: 4.003

10.  Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.

Authors:  Amaryllis H Van Craenenbroeck; Evelien L J Smits; Sébastien Anguille; Ann Van de Velde; Barbara Stein; Tessa Braeckman; Kirsten Van Camp; Griet Nijs; Margareta Ieven; Herman Goossens; Zwi N Berneman; Viggo F I Van Tendeloo; Gert A Verpooten; Pierre Van Damme; Nathalie Cools
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.